Skip to main content
. 2018 Mar;10(3):1569–1577. doi: 10.21037/jtd.2018.03.05

Table 3. Multivariate analyses for DFS and OS.

Variables Hazard ratio P value
DFS
   CTC count (≥2) 3.28 (1.24–8.67) 0.017
   CEA (>5 ng/mL) 4.12 (2.25–7.57) <0.001
   Number of lung metastases (multiple) 2.04 (1.12–3.71) 0.037
   History of liver metastasis (present) 1.32 (0.69–2.53) 0.403
   Disease-free interval (≤24 months) 2.45 (1.10–5.45) 0.028
OS
   CTC count (≥2) 2.51 (0.69–9.09) 0.176
   CEA (>5 ng/mL) 5.74 (1.63–20.15) 0.006
   Disease-free interval (≤24 months) 5.09 (0.61–42.45) 0.133

CTC, circulating tumour cell; CEA, carcinoembryonic antigen; DFS, disease-free survival; OS, overall survival.